IL129957A - Substituted phenols and phenyl esters and pharmaceutical compositions containing them - Google Patents

Substituted phenols and phenyl esters and pharmaceutical compositions containing them

Info

Publication number
IL129957A
IL129957A IL12995797A IL12995797A IL129957A IL 129957 A IL129957 A IL 129957A IL 12995797 A IL12995797 A IL 12995797A IL 12995797 A IL12995797 A IL 12995797A IL 129957 A IL129957 A IL 129957A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
substituted phenols
phenyl esters
esters
Prior art date
Application number
IL12995797A
Other languages
English (en)
Other versions
IL129957A0 (en
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of IL129957A0 publication Critical patent/IL129957A0/xx
Publication of IL129957A publication Critical patent/IL129957A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/18Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
    • C07C39/19Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
IL12995797A 1996-11-20 1997-10-07 Substituted phenols and phenyl esters and pharmaceutical compositions containing them IL129957A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75552896A 1996-11-20 1996-11-20
PCT/US1997/018055 WO1998022418A1 (en) 1996-11-20 1997-10-07 Substituted phenols and thiophenols useful as antioxidant agents

Publications (2)

Publication Number Publication Date
IL129957A0 IL129957A0 (en) 2000-02-29
IL129957A true IL129957A (en) 2005-06-19

Family

ID=25039544

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12995797A IL129957A (en) 1996-11-20 1997-10-07 Substituted phenols and phenyl esters and pharmaceutical compositions containing them

Country Status (22)

Country Link
EP (1) EP0942896B1 (pt)
JP (2) JP4267705B2 (pt)
KR (2) KR100648118B1 (pt)
CN (1) CN1168693C (pt)
AR (1) AR009429A1 (pt)
AT (1) ATE237574T1 (pt)
AU (1) AU734050B2 (pt)
BR (1) BR9713372A (pt)
CA (1) CA2271054C (pt)
DE (1) DE69721040T2 (pt)
DK (1) DK0942896T3 (pt)
ES (1) ES2191828T3 (pt)
HK (1) HK1021970A1 (pt)
HU (1) HUP9904244A3 (pt)
IL (1) IL129957A (pt)
NO (1) NO318039B1 (pt)
NZ (1) NZ335440A (pt)
PT (1) PT942896E (pt)
SI (1) SI0942896T1 (pt)
TW (1) TW508349B (pt)
WO (1) WO1998022418A1 (pt)
ZA (1) ZA9710315B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852878B2 (en) 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
DK0981343T3 (da) 1997-05-14 2006-01-30 Atherogenics Inc Probucolmonoestere til behandling af kardiovaskulær og inflammatorisk sygdom
EP1695959A1 (en) * 1997-05-14 2006-08-30 Atherogenics, Inc. Compouds and methods for the inhibition of the expression of VCAM-1
US6020383A (en) * 1999-01-11 2000-02-01 Eastman Chemicals Company Method for reducing blood cholesterol and/or blood triglycerides
CN100512809C (zh) * 2001-10-25 2009-07-15 阿特罗吉尼克斯公司 化合物在制备用于慢性移植排斥的药物中的用途
WO2005102323A2 (en) 2004-04-20 2005-11-03 Atherogenics, Inc. Process of preparing esters and ethers of probucol and derivatives thereof
KR100725582B1 (ko) 2004-06-29 2007-06-08 주식회사 동부하이텍 식물병원균의 생장억제활성을 갖는 알킬페놀 유도체
JP5191739B2 (ja) * 2004-12-22 2013-05-08 チバ ホールディング インコーポレーテッド 抗ラジカル剤
US8252840B2 (en) 2007-03-26 2012-08-28 Salutria Pharmaceuticals Llc Methods of derivatives of probucol for the treatment of type II diabetes
KR101420083B1 (ko) * 2012-04-04 2014-07-15 이화여자대학교 산학협력단 Uch-l1 저해 화합물 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 uch-l1 관련 질환의 예방 또는 치료용 약학적 조성물
WO2014185561A1 (ko) * 2013-05-13 2014-11-20 이화여자대학교 산학협력단 신규한 화합물 또는 이의 약학적으로 허용 가능한 염 및 이를 유효성분으로 함유하는 uch-l1 관련 질환의 예방 또는 치료용 약학적 조성물
WO2016170704A1 (ja) * 2015-04-23 2016-10-27 株式会社日本ハイポックス 慢性呼吸器疾患治療剤及び心臓の線維化抑制組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57176038A (en) * 1981-04-21 1982-10-29 Fuji Photo Film Co Ltd Silver halide color photographic material
CA2050514A1 (en) * 1990-09-14 1992-03-15 Bradley C. Pearce Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
DE4109627A1 (de) * 1991-03-23 1992-09-24 Boehringer Mannheim Gmbh Neue phenolether, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
CA2096496A1 (en) * 1992-05-29 1993-11-30 Bradley C. Pearce Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
EP0589069B1 (en) * 1992-09-18 1997-01-29 Nippon Hypox Laboratories Incorporated Hydroquinone derivatives and antioxidants and tumor inhibitors containing them
JP3050733B2 (ja) * 1992-10-16 2000-06-12 中外製薬株式会社 4−アルコキシ−2,6−ジ−t−ブチルフェノール誘導体
TW393475B (en) * 1992-10-16 2000-06-11 Chugai Pharmaceutical Co Ltd 4-alkoxyl-2,6-di-t-butyl phenol derivatives

Also Published As

Publication number Publication date
SI0942896T1 (en) 2003-08-31
NO318039B1 (no) 2005-01-24
CN1168693C (zh) 2004-09-29
CA2271054C (en) 2005-12-13
EP0942896A1 (en) 1999-09-22
PT942896E (pt) 2003-07-31
JP2001504483A (ja) 2001-04-03
NO992390D0 (no) 1999-05-19
CA2271054A1 (en) 1998-05-28
AU4809897A (en) 1998-06-10
HK1021970A1 (en) 2000-07-21
EP0942896B1 (en) 2003-04-16
JP4267705B2 (ja) 2009-05-27
HUP9904244A2 (hu) 2000-09-28
KR20060016839A (ko) 2006-02-22
AR009429A1 (es) 2000-04-12
NZ335440A (en) 2001-07-27
NO992390L (no) 1999-07-16
DK0942896T3 (da) 2003-07-28
AU734050B2 (en) 2001-05-31
KR100698995B1 (ko) 2007-03-26
WO1998022418A1 (en) 1998-05-28
KR20000057135A (ko) 2000-09-15
IL129957A0 (en) 2000-02-29
DE69721040T2 (de) 2003-10-16
ZA9710315B (en) 1998-05-20
HUP9904244A3 (en) 2002-07-29
BR9713372A (pt) 2000-03-21
CN1237955A (zh) 1999-12-08
KR100648118B1 (ko) 2006-11-28
JP2009132710A (ja) 2009-06-18
ES2191828T3 (es) 2003-09-16
ATE237574T1 (de) 2003-05-15
DE69721040D1 (de) 2003-05-22
TW508349B (en) 2002-11-01

Similar Documents

Publication Publication Date Title
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
IL122447A0 (en) Pharmaceutical composition with anaestheric effect
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
EG24118A (en) Pharmaceutical compositions
GB9615089D0 (en) Esters and compositions comprising them
HUP0000733A3 (en) Aminoguanidines and alkoxyguanidines as and pharmaceutical compositions containing them
EP0943327A4 (en) DRUG
HUP0001309A3 (en) 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them
HUP9901452A3 (en) Bicyclic-aromatic compounds and pharmaceutical compositions containing them
IL128058A0 (en) Illudin analogs and pharmaceutical compositions containing the same
GB9616672D0 (en) Pharmaceutical compositions
GB9623205D0 (en) Novel pharmaceutical compositions
IL129957A (en) Substituted phenols and phenyl esters and pharmaceutical compositions containing them
PL331423A1 (en) Muporocin and chlorohexidrin containing compositions
GB9610359D0 (en) Pharmaceutical compositions
IL125998A0 (en) Taxoids preparation thereof and pharmaceutical compositions containing them
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
ZA979726B (en) Pharmaceutical compositions
GB9606429D0 (en) Pharmaceutical compositions
GB9613457D0 (en) Pharmaceutical compositions
SG87031A1 (en) Cynanate ester composition and cured product thereof
GB9623962D0 (en) Pharmaceutical composition
GB9618376D0 (en) Pharmaceutical compositions
GB9610136D0 (en) Pharmaceutical compositions
IL155070A0 (en) Novel phenyl esters

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees